GeneLink, Inc.
Dermagenetics maker retains Equitilink, LLC, for investor relations
Published in Genetics and Environmental Business Week, March 10th, 2005
A San Diego, California agency, Equitilink provides a variety of custom services for public companies seeking results-oriented investor relations programs.
According to John DePhillipo, chairman and CEO of GeneLink, "Equitilink is a good fit for GeneLink as we enter what should be a break-through year for GeneLink and Dermagenetics. The professionals at Equitilink are very knowledgeable of small-cap and micro-cap stocks,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Ardana Bioscience
Agreement with U.K. Medical Research Council extended - Avanir Pharmaceuticals
Pharmaceutical firm reports loss of $0.07 per share - Genaissance Pharmaceuticals, Inc.
Pharmacogenomic-focused pharma reports increased revenues and losses in 2004 - Humanetics Corporation
USU and HJF sign agreement for development of radiation protection compounds - Myriad Genetics, Inc.
Biopharma company reports second quarter results - Peplin Limited
Company releases financial results, provides summary of R&D efforts - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
